Drug profile · INN
linagliptin
JENTADUETO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
linagliptin (JENTADUETO) is an FDA-listed pharmaceutical active ingredient. Associated with Sunshine Biopharma. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN linagliptin
Brand JENTADUETO
Route ORAL
Formulation TABLET, EXTENDED RELEASE
ATC code A10BD11
Originator Sunshine Biopharma
Frequently asked questions
What is linagliptin?
linagliptin (JENTADUETO) is an FDA-listed pharmaceutical active ingredient. Associated with Sunshine Biopharma. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for linagliptin?
JENTADUETO is a marketed brand name for linagliptin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of linagliptin?
linagliptin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.